Research Topic: fungal pneumonia

Fungal Pneumonia and Severe Neutropenia: Risk Factors for Increased 90 Day Mortality

This study examined 39 cancer patients with severe fungal lung infections treated at a major cancer center. Patients who received antifungal treatment within 7 days and started with a specific drug called liposomal amphotericin B had better survival rates at 90 days. The research suggests that quick diagnosis and prompt treatment initiation are critical for improving survival in immunocompromised patients with fungal pneumonia.

Read More »

A case of Blastomyces helicus pneumonia in a dog from a non-endemic region: diagnostic challenges and successful treatment outcome

A dog from Colorado developed a severe respiratory infection that was initially mistaken for a bacterial pneumonia. After antibiotics failed to help, advanced testing revealed the dog had a fungal infection caused by Blastomyces helicus, a rare fungus found in western North America. The dog was successfully treated with an antifungal medication called itraconazole and made a complete recovery within six months, demonstrating the importance of considering fungal infections when standard treatments fail.

Read More »

A case of Blastomyces helicus pneumonia in a dog from a non-endemic region: diagnostic challenges and successful treatment outcome

A dog developed severe pneumonia from an emerging fungal infection called Blastomyces helicus after traveling to Utah and Idaho. Initial blood tests incorrectly suggested a different fungus, but laboratory culture and genetic testing identified the true culprit. The dog was successfully treated with an antifungal medication called itraconazole and made a complete recovery with careful monitoring over 6 months.

Read More »

A Case of Pulmonary Infection Due to Magnusiomyces capitatus in a Non-Immunocompromised Patient with Cerebral Palsy

A young man with cerebral palsy developed a rare lung infection caused by Magnusiomyces capitatus, a fungus that usually only affects people with weakened immune systems. Doctors diagnosed the infection by analyzing fluid from his lungs and identified the fungus using advanced laboratory techniques. The patient improved after being treated with an antifungal medication called voriconazole. This case highlights that this rare fungal infection can occur in otherwise healthy people, especially those with conditions affecting their ability to clear lung secretions.

Read More »
Scroll to Top